TickerTain
TickerTain
NewsroomShortsPortfolioConvergence
NewsroomShortsPortfolioConvergence
←

$EXAS

Exact Sciences
···
sign in to save

Exact Sciences develops diagnostic tests and solutions for early cancer detection.

sentiment mix
bull 100%bear 0%neu 0%

signal summary

latest thesis
Exact Sciences' Cologuard stool test proves commercial viability of non-invasive colorectal screening▾

Stool-based test with incredible predictive ability for colorectal cancer risk has established a growing market, validating the category for liquid biopsy approaches; colonoscopy avoidance creates massive addressable population.

alex cornellT1Invest Like The Best2026-04-21
confidence 82 / 100impact Medium
key themes
  • Healthcare Systems & Policy100%
  • GLP-1 & Metabolic Drugs100%
  • AI Drug Discovery100%
  • Oncology100%
  • Cardiovascular Disease100%

bull thesis · 1

93 / 100
  • •Exact Sciences' Cologuard stool test proves commercial viability of non-invasive colorectal screening

bear thesis · 0

—
  • — none —

mentions · 1

Invest Like The BestGLP-1s, Peptides, and The Trillion-Dollar Health Revolution1 mentions · 1▲ 0▼ 0○ · 5 months ago
0:0016:0032:0048:001:05:00